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S266 Poster Session IIneutropenia incidence increase with regimen dose intensity
(52.38% for myeloablative, 36.8% non myeloablative and 25%
with minimal intensity). The stomatitis severe mortality is 26%
in our study group (100% by multiple organic failures without
difference between preparative regimens: 9.5% in myeloablative,
10.5% non myeloablative and 8.3% with minimal intensity)
into 50 days after transplantation and it delay hospital outpatient
day (29.3 vs 22.3 days). These parameters not impact on myeloid
graft day between vary regimens (14.3 vs 14 days) that represent
stomatitis resolution.
Conclusions: Preparative regimen with more intensity represent
more stomatitis severity in addition to increase adverse effects (fe-
brile neutropenia, opiate infusions use and total parenteral nutri-
tion) that represent another complications although they don’t
have impact on myeloid graft day and mortality by process.292
CASE STUDY: ALLOGENEIC HEMATOPOETIC STEM CELL TRANSPLANTA-
TION (HSCT) FROM POINT OF VIEW OF THE PATIENT, THE DATA MAN-
AGER AND THE PHYSICIANS
Larsen, H.B.1,2, Roepstorff, C.1, Petersen, H.1, Sengeløv, H.1,
Heilmann, C.J.2 1Rigshospitalet, Copenhagen, Denmark; 2Rigshospitalet,
Copenhagen, Denmark
Introduction: Being a data manager in a HSCT-unit implies to cap-
tur accurate data from the patients medical record regarding the pa-
tients condition and complications.
Aim: The aim of this case study is to analyse the patient’s (pt) com-
plications from different view point[pos]s and to question if we cap-
ture all relevant information and from whose perspective.
Patient and Methods: We have selected a single pt. and performed
an in-dept interview to illustrate the different perspectives regarding
the patient’s complications.
The pt. is female (d.o.b 1978) diagnosed with Fanconi anemia in
1987, who developed MDS (RA) in 1999 and who were not treated
with chemotherapy before HSCT. Conditioning: CTX 10 mg/kg
in 4 days, Bu p.o. 0,375 mg/kg times 4 in 4 days. GvHD profylaxis:
CyA and MTX. She was transplanted with a matched sibling donor
in 2001. After the HSCT she faced a number of complications and
died as a result of these in 2009.
Results: See table 1.
Conclusion: Data Collection capture most of the pt.’s medical com-
plications and the physicians treatment of these, however the psy-
chosocial related issues also have a major impact on the pt.’s
quality of life, but these issues are not documented in any detail.Results
Data Managers report Physicians persp
Acute GvHD:2001 Grade III, (Skin stage III,
Gut stage II, Liver stage III)
CyA, Systemic steroids
Chronic GvHD: 2001 Extensive, Mild
(onset) developed to severe, Oral cavity:
Lichinoid changes, Ulcers, Liver:
Increased enzymes, Vagina: Agglutination,
dryness, Eyes: Dryness, conjunctivitis,
coronal erosions,
CyA, Steroids, MMF, Traco
2004, 2008, 2009 Corne
transplantations
Secondary cancer: 2002: Tongue
(Planocellulary carcinoma), 2006: Vulva
(Planocellulary carcinoma), 2008: Eye
(Squamous carcinoma), 2009: Cervix
Cancer stage II A
Removal of tumor, Remova
labia minor and major, R
eye, Hysterectomia with
Other Complications: 2003 and 2007:
Aseptic Bone Necrosis in hip, 2004:
Aseptic Bone Necrosis in knee, 2006:
Depression, 2006, 2008: Suicide Attempt
(pills)
Hip replacement of both hi
replacement, Medical tre
depressionThe pt.’s psychosocial well-being is often discussed and requires at-
tention, but are not systematically gathered in data collection. The
lack of a systematical collection of psychosocial information may
have an impact on the research questions asked within the field of al-
logeneic HSCT, so research related to the psychosocial perspective
do not revieve the same systematical and world wide attention.293
INDICATIONS AND OUTCOME OF STEM CELL TRANSPLANT AT THE AGA
KHAN UNIVERSITY HOSPITAL
Ali, N., Adil, S., Shaikh, U., Naz, N., Masood, N. The Aga Khan Uni-
versity Hospital
Objective:To determine indications, morbidity and mortality of Al-
logeneic and Autologous stem cell transplant.
Subjects andMethods: All patients who presented in bone marrow
transplant clinic with a potentially curable disease were included in
the study. Pre-transplant workup of the patient and donor included
a complete blood count, evaluation of liver, kidney, lung, infectious
profile, chest and paranasal sinus roentgenograms and dental review.
Mobilization was done with G-CSF 300mcg twice daily. The condi-
tioning regimens included Busulfan/Cyclophosphamide, Cyclo-
phosphamide/ATG/Fludarabine. BEAM, ICE and high dose
Melphalan. Chimerism studies were done by fluorescent in situ hy-
bridization (FISH) and variable non tandem repeats (VNTR) tech-
niques.
Results: A total of 98 transplants were done from April 2004 – Feb-
ruary 2009. Out of these n5 58 were allogeneic bone marrow trans-
plants whereas n5 40 were autologous transplant. There were
n5 73 males and n5 25 females. n5 35 were in the pediatric age
group (\15 years) while n5 63 were adults (.15 years). The main
indications for Allogeneic stem cell transplant were Aplastic Anemia
(n5 20) followed by Thalassemia Major (n5 16). For the autolo-
gous transplant, Non-Hodgkin’s Lymphoma was the most common
indication (n5 14) followed by Hodgkin’s disease (n5 9). Trans-
plant related mortality was 11.3% and 20.6% in Allogeneic and Au-
tologous procedures respectively. Causes of mortality included grade
IV GvHD, fungal infections, acute appendicitis and pneumonia.
Conclusion: A total of 98 stem cell transplants were done. The
transplant related mortality was higher in autologous transplant.
Common indications included Thalassemia Major, Aplastic Anemia
and Non Hodgkin’s Lymphoma.ective Patient experience
Prolonged hospitalisation, side effects from
medicine
limus, Sirolimus
a
Weight loss (diarrheoa, loss of appetite), Pain
and bleeding from vagina, dilataion of vagina
daily, loss of sexual pleaure. Loss of vision,
pain, everyday life as blind
l of clitoris and
emoval of one
B.S.O.
Fear of death, Loss of sexual pleasure, Loss of
vision of one eye, Loss of fertility
ps, Knee
atment for
Loss of physical function in a periode,
Psychotherapy, Feeling stigmatised, Psycho-
social relations: Loss of education, Loss of
work, Loss of spouse, friends, and strain on
family relations, Live with handicaps
